These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 36830870)
1. Therapeutic Plasma Exchange in Certain Immune-Mediated Neurological Disorders: Focus on a Novel Nanomembrane-Based Technology. Tonev DG; Momchilova AB Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830870 [TBL] [Abstract][Full Text] [Related]
2. Principles of Therapeutic Apheresis in Neurological Disease. Strasser E Transfus Med Hemother; 2023 Apr; 50(2):88-97. PubMed ID: 37066058 [TBL] [Abstract][Full Text] [Related]
3. Our Clinical Experience in the Treatment of Myasthenia Gravis Acute Exacerbations with a Novel Nanomembrane-Based Therapeutic Plasma Exchange Technology. Tonev D; Georgieva R; Vavrek E J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887784 [TBL] [Abstract][Full Text] [Related]
4. Comparison of IVIg and TPE efficacy in the treatment of neurological disorders: a systematic literature review. Pinto AA; De Seze J; Jacob A; Reddel S; Yudina A; Tan K Ther Adv Neurol Disord; 2023; 16():17562864231154306. PubMed ID: 37006460 [TBL] [Abstract][Full Text] [Related]
5. Plasmapheresis in neurological disorders: six years experience from University Clinical center Tuzla. Sinanović O; Zukić S; Burina A; Pirić N; Hodžić R; Atić M; Alečković-Halilović M; Mešić E F1000Res; 2017; 6():1234. PubMed ID: 28928949 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic Plasma Exchange in Patients with Neurologic Disorders: Review of 63 Cases. Tombak A; Uçar MA; Akdeniz A; Yilmaz A; Kaleagası H; Sungur MA; Tiftik EN Indian J Hematol Blood Transfus; 2017 Mar; 33(1):97-105. PubMed ID: 28194064 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic plasma exchange in the neurologic intensive care setting recommendation for clinical practice. Kes P; Basić-Kes V; Basić-Jukić N; Demarin V Acta Clin Croat; 2012 Mar; 51(1):137-53. PubMed ID: 22920015 [TBL] [Abstract][Full Text] [Related]
16. Safety and tolerability of therapeutic plasma exchange in autoimmune neurological diseases - a retrospective single-centre analysis. Gala-Błądzińska A; Mazur K; Dębiec A; Gargasz K; Bartosik-Psujek H Neurol Neurochir Pol; 2020; 54(4):344-349. PubMed ID: 32557528 [TBL] [Abstract][Full Text] [Related]
17. The Role of Plasma Exchange in the Treatment of Refractory Autoimmune Neurological Diseases: a Narrative Review. Jacob S; Mazibrada G; Irani SR; Jacob A; Yudina A J Neuroimmune Pharmacol; 2021 Dec; 16(4):806-817. PubMed ID: 34599742 [TBL] [Abstract][Full Text] [Related]
19. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum. Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic plasma exchange for myasthenia gravis, Guillain-Barre syndrome, and other immune-mediated neurological diseases, over a 40-year experience. Fernández-Fournier M; Kerguelen A; Rodríguez de Rivera FJ; Lacruz L; Jimeno S; Losantos I; Hernández-Maraver D; Puertas I; Tallon-Barranco A; Viejo A; Frank García A; Díez-Tejedor E Expert Rev Neurother; 2022 Oct; 22(10):897-903. PubMed ID: 36408604 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]